Finding promising treatments through clinical trials offers renewed hope to patients and families. With the right support, the path to these opportunities becomes faster, clearer, and more accessible.

Carebox helps patients discover relevant, potentially life-changing treatment options available only in clinical trials. In parallel, its customers -- including pharmaceutical companies sponsoring trials, research centers / hospitals conducting them, and patient advocacy groups guiding patients through their journeys -- gain from enhanced enrollment while promoting diversity and patient-centricity.  

“It’s a win-win for our pharma company customers and the patients they serve. By helping patients access the right treatment options in clinical trials, we help trial sponsors and research sites achieve their clinical trial enrollment goals,” says Brian Weiss, CEO.

At the core of this effort is Carebox Connect, a modular, turnkey SaaS platform which addresses the most pressing challenges patients and caregivers face: identifying which clinical trials are relevant to their unique medical circumstances.

“It’s a win-win for our pharma company customers and the patients they serve. By helping patients access the right treatment options in clinical trials, we help trial sponsors and research sites achieve their clinical trial enrollment goals.”

Brian Weiss
CEO of Carebox

In public registries, clinical trial eligibility criteria can only be reviewed one study at a time. There is no way to identify which studies are relevant to a patient’s specific condition, treatment history and disease stage.   

Carebox’s unique ConditionMatch capability allows patients or family members to answer five to ten questions about their condition, treatment history, and personal characteristics related to their illness. Using this information, the platform identifies trials for which the patient is potentially eligible to participate. Next, a small number of more detailed questions associated with the identified trials further pinpoint relevant trials and ensure the patient is properly pre-qualified to be referred to a trial site. ConditionMatch thus simultaneously serves two functions: it identifies potentially relevant trials for patients, and it pre-screens for any such trial that is selected.

Without ConditonMatch, trial sponsors and their patient recruitment vendors must continuously develop and maintain pre-screeners for every study recruitment program. This has very high costs and limits the number of trials that can afford such programs. Without ConditionMatch, the vast majority patients who complete a pre-screener and don’t qualify for the study that they initially thought might be relevant, hit a dead end. 

With ConditionMatch, however, all trials can have recruitment and referral programs. Patients who aren’t eligible for an initial trial of interest are presented with alternatives and can also sign up for automatic notifications about future trial opportunities based on their ConditionMatch questionnaire responses, supporting them throughout their patient journey.

ConditionMatch ensures optimal identification of relevant trials for patients and highly qualified referrals for trial sites. When patients find a promising trial that is relevant, the Carebox platform connects them with nearby research sites directly or via seamless integration with many leading recruitment service providers. It follows up with both the patient and the site – both digitally and with optional call center navigation services - and provides trial sponsors with visibility on outcomes. The platform tracks engagement and activity so trial sponsors better understand the impact of their outreach efforts to refine their strategies for greater effectiveness.

By partnering with dozens of patient advocacy groups, Carebox brings its solution directly to where patients are actively seeking treatment options and guidance. Over the past 18 months, Carebox has nearly doubled the number of advocacy groups, including some of the most respected and well-known nonprofits in the healthcare space, spanning a broad spectrum of diseases.

30 percent of the top 10 global pharmaceutical companies use the platform. One such company has implemented a branded version of Carebox Connect that supports almost 100 clinical trials across dozens of therapeutic areas. The platform drives high-quality referrals to research sites and enables streamlined enrollment while delivering operational efficiencies and the flexibility to evolve alongside customer needs.

Carebox Connect delivers on the company’s mission to empower patients and families with clarity and choice while equipping its pharma customers with the tools they need to accelerate clinical trial recruitment and drive better outcomes.

This article was originally featured in Life Sciences Review.

About Carebox

Carebox connects patients and physicians seeking treatment options with clinical trials. For patients and families, access to information about the newest and most advanced treatment options is obscured and frustrating to find. For pharma companies, clinical trial recruitment is the primary bottleneck in the $100B+ drug development market now being reshaped by precision medicine treatment specificity, new trial models, diversity requirements, and digital health consumer expectations. Carebox is at the forefront of addressing these challenges for patients and their families, as well as for the ecosystem of companies involved in sponsoring, running, and recruiting for clinical trials. Learn more about Carebox at careboxhealth.com.